Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 4Colorectal Neoplasms 4Breast Neoplasms 4Vitamin D Deficiency 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma 2Leukemia 2Colonic Neoplasms 2Thyroiditis 1Prostatic Neoplasms 1Polyps 1Polycystic Ovary Syndrome 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Osteoporosis Secondary 1Obesity 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hypocalcemia 1Hyperthyroidism 1Goiter 1Colonic Polyps 1Bone Diseases, Metabolic 1Arthralgia 1Adenomatous Polyps 1Adenoma 1

Interventions

Metformin 139Clomiphene 44Letrozole 36Inositol 28Folic Acid 17Exercise 17Progesterone 16Ethinyl Estradiol 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Chorionic Gonadotropin 10Triptorelin Pamoate 9Tablets 9Spironolactone 8Diet 8Cholecalciferol 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Menotropins 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7drospirenone 6Ovidrel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polycystic Ovary Syndrome × Calcium Carbonate × Clear all
NCT03792984 2019-06-06

The Effect of Calcium and Vitamin D Supplements on Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Patients

Damascus University

Phase 3 Completed
40 enrolled

Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡